on 29 Sept 2021
Last Applicant/ Owned by
Good Psyence (PTY) Ltd
14 Kloof Street Gardens, Cape Town, Western Cape 8001
, ,
Serial Number
UK00003703735 filed on 29th Sept 2021
Registration Number
UK00003703735 registered on
31st Dec 2021
Correspondent Information
Murgitroyd & Company
Murgitroyd House, 165-169 Scotland Street
Glasgow,
G5 8PL
Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use, food for babies; dietary supplements for human beings and animals; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; anti-epileptic pharmaceutical preparations; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis; pharmaceutical preparations for the treatment of drug and alcohol abuse; pharmaceutical preparations for the treatment of headaches; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; pharmaceutical preparations for the treatment of smoking cessation; pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system namely brain, movement, ocular motility and spinal cord diseases; preparations for the relief of pain; nutritional supplements, namely nutraceutical products in the form of beverages and edibles; biochemical preparations, namely psilocybin mushroom extract; biochemical preparations, namely psilocin mushroom extract; psilocybin; psilocin; preparations containing psilocybin; preparations containing psilocin; herbal supplements containing psilocybin; herbal supplements containing psilocin; dietary and nutritional supplements, namely mushroom extracts; preparations for the treatment of mental health disorders; pharmaceutical preparations and herbal supplements for enhancing mental health; pharmaceutical preparations, namely cognitive enhancers; herbal supplements, namely cognitive enhancers; dietary supplements for enhancing mental health, and for the treatment of mental health disorders; dietary and nutritional supplements for alleviating symptoms experienced in the palliative care setting namely, nausea, anorexia, cachexia, severe intractable pain, severe depressed mood, and insomnia; plant-based supplements for aiding general health, well-being and cognitive function; nutritional and dietary supplements, namely, mushrooms and mushroom extracts in capsule, liquid and powder form.
UK00003703735
Word
Individual